Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.21)
# 751
Out of 5,044 analysts
12
Total ratings
72.73%
Success rate
12.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEPG PepGen | Maintains: Buy | $12 → $18 | $4.71 | +282.17% | 2 | Oct 27, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $69.92 | +2.97% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $4.51 | +432.15% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $1.63 | +1,130.77% | 1 | Sep 30, 2025 | |
| MAZE Maze Therapeutics | Reiterates: Buy | $50 | $32.50 | +53.85% | 3 | Sep 18, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $3.49 | +301.15% | 1 | Aug 15, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $75 → $60 | $29.38 | +104.26% | 1 | Aug 7, 2025 |
PepGen
Oct 27, 2025
Maintains: Buy
Price Target: $12 → $18
Current: $4.71
Upside: +282.17%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $69.92
Upside: +2.97%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $4.51
Upside: +432.15%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $1.63
Upside: +1,130.77%
Maze Therapeutics
Sep 18, 2025
Reiterates: Buy
Price Target: $50
Current: $32.50
Upside: +53.85%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $3.49
Upside: +301.15%
Structure Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $29.38
Upside: +104.26%